Radio and PodcastLive Radio & Podcasts

Search Radio and Podcast

Podcasts›OncLive® On Air›S18 Ep26: FDA Approval Insights: Gedatolisib Plus Fulvestrant ± Palbociclib for HR+, HER2-Negative, PIK3CA Wild-Type Advanced Breast Cancer: With Adam M. Brufsky, MD, PhD

Science & Medicine

S18 Ep26: FDA Approval Insights: Gedatolisib Plus Fulvestrant ± Palbociclib for HR+, HER2-Negative, PIK3CA Wild-Type Advanced Breast Cancer: With Adam M. Brufsky, MD, PhD

OncLive® On Air by Audioboom

Aug 14, 202610:47Science & Medicine

In today’s episode, we spoke with Adam M. Brufsky, MD, PhD, about the FDA approval of gedatolisib (Revtorpyk) plus fulvestrant (Faslodex), with or without palbociclib (Ibrance), for the treatment of adult patients with h...

Related Episodes

Continue listening to more episodes from OncLive® On Air.

S18 Ep33: Current Approaches and Future Directions for Early-Stage TNBC

Sep 4, 2026 - 28:35

Highlights from the PER® CME activity "Current Approaches and Future Directions for Early-Stage TNBC" — t...

S18 Ep32: Non–Small Cell Lung Cancer 2026 UPDATE

Aug 31, 2026 - 13:48

Two Onc Docs , hosted by Samantha A. Armstrong, MD, and Karine Tawagi, MD, is a podcast dedicated to prov...

S18 Ep31: FDA Approval Insights: Integrating RP1 Plus Nivolumab Into Post–PD-1 Melanoma Practice: With Michael K. Wong, MD, PhD, FRPC

Aug 28, 2026 - 22:12

In today's episode, we spoke with Michael K. Wong, MD, PhD, FRPC. Dr Wong is a physician at Roswell Park...

S18 Ep31: Immunotherapy Decision-Making in CSCC Sits at the Intersection of Efficacy and Comorbidity: With Eric D. Whitman, MD; and Francis Paul Worden, MD

Aug 28, 2026 - 27:52

Eric D. Whitman, MD, and Francis Paul Worden, MD, discuss the integration of immunotherapy into the cutan...

S18 Ep30: FDA Approval Insights: Iberdomide-Based Therapy Adds Another Option for R/R Myeloma: With Sagar Lonial, MD, FACP, FASCO

Aug 27, 2026 - 8:01

In today’s episode, we welcomed Sagar Lonial, MD, FACP, FASCO, to discuss the significance of the August...

S18 Ep29: 𝘔𝘌𝘛 Alterations in NSCLC: Applying Diagnostic Advances and Targeted Therapies in a New Era of Treatment

Aug 24, 2026 - 29:14

Highlights from the PER® CME activity " MET Alterations in NSCLC: Applying Diagnostic Advances and Target...

S18 Ep28: Pancreatic Cancer Treatment Advances Call for a Renewed Focus on the Role of Liposomal Irinotecan: With Jennifer B. Valerin, MD, PhD

Aug 20, 2026 - 17:02

In today’s episode, we spoke with Jennifer B. Valerin, MD, PhD. Dr Valerin is an assistant professor in t...

S18 Ep27: Key Considerations for Health Equity and Patient-Centered Care in TNBC

Aug 17, 2026 - 25:59

Highlights from the PER® CME activity "Key Considerations for Health Equity and Patient-Centered Care in...